Presentation TCT 2025 TCT 1005: Point-of-Care Genotype-Guided Antiplatelet Strategy Using Spartan RX: Pharmacodynamic Comparison of Prasugrel and Ticagrelor in Korean PCI Patients with CYP2C19 LOF Alleles Presenter: Ji-Wung Ryu October 27, 2025
Presentation TCT 2025 TCT 300: Ticagrelor Removal to Reduce Bleeding after Urgent CABG: Registry and Individual Patient-level Meta-analysis of Observational Data Presenter: Matthias Thielmann October 26, 2025
Presentation TCT 2025 TCT 56: Impact of age on the efficacy and safety of ticagrelor monotherapy in patients with acute coronary syndrome: A pooled analysis from the TICO and T-PASS Trials Presenter: Sun Oh Kim October 26, 2025
Presentation TCT 2025 TCT 54: Outcomes with Ticagrelor Versus Clopidogrel for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Propensity-Matched Analysis Presenter: Ahmed Younes October 26, 2025
Presentation TCT 2025 TCT 53: Outcomes with Ticagrelor versus Prasugrel for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Propensity-Matched Analysis Presenter: Ahmed Younes October 26, 2025
Presentation TCT 2025 TCT 1707: Ticagrelor Resistance Causing Acute In-Stent Thrombosis: Successful Management With Prasugrel and Balloon Angioplasty Presenter: Kaiyu Jia October 26, 2025
Presentation TCT 2025 Short-Term Outcomes of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention For ST-Elevation Myocardial Infarction Presenter: Eva Christine Ida Woelders October 25, 2025
News Daily News Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years Yael L. Maxwell June 09, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News SCAD Story Fleshed Out by Clues About Causes, Treatment Risks Yael L. Maxwell March 13, 2025